AFT Pharmaceuticals Limited (NSX:AFT) (ASX:AFP) today reports it has again achieved another year of record revenue with annual sales exceeding $200 million1 and it is now firmly focused on its revenue target of $300 million by the end of the 2027 financial year.
Newsmatics’ innovative products took center stage for students at Masaryk University in Brno, Czech Republic, giving them a firsthand look at how the company’s state-of-the-art tool is transforming the news industry through data science.
pRxEngage, a groundbreaking platform designed to transform how clinical trials connect with patients, has officially launched. Created to simplify patient engagement with clinical trials, pRxEngage provides patients, researchers, and biopharma sponsors with clear, actionable pathways to trial enrolment.
Amid ongoing NIH budget cuts, regulatory slowdowns, and surging domestic trial costs, U.S. Contract Research Organizations (CROs) are increasingly outsourcing global trials to Australia.
MultiRater Surveys, a cloud-based leadership survey provider, announced today the release of MyMentor Insights. “MyMentor Insights delivers an exciting leap forward in the goal of being able to provide businesses of all sizes with the ability to develop leadership capability at all levels.
In this compelling episode of The Ellis Martin Report, host Ellis Martin engages in a powerful and enlightening conversation with Michael Breen, CEO and Managing Director of GT Biopharma Inc. (NASDAQ:GTBP).
The story began with an article published by none other than the esteemed Harvard University in 2023, extolling the benefits of “eating down the seafood chain”—in other words, eating sardines.
